MLS Capital
VC · (Malaysia)
VC
Series B
Healthcare
Hardware
Sign up free to access full profile and submit your pitch.
About
MLS Capital Fund II (MLSCF II), co-managed by Spruce Capital Partners and Xeraya Capital, will invest the funds in a diversified portfolio of biogreentech companies at all stages of development. Biogreentech spans plant and animal agriculture; food, feed, and nutrition; bio-renewable chemicals and materials; and adjacent opportunities along the value chain, including “big data" analytics, robotics, production, harvesting and use of natural resources, and synthetic biology.
Visit website ↗Investment Criteria
Sign up free to see full investment criteria and submit your pitch.
Min. Ticket Size
$1,000,000
Max. Ticket Size
$5,000,000
Min. Revenue (ARR)
$5,000,000
Investment Stage
Series B
Focus Areas
Regions
Southeast Asia
